Pancreatic Cancer Research

Journal articleMol Biol Cell2016

Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.

Journal
Mol Biol Cell
Published
28 September 2016
Citations
25
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Pancreatic ductal adenocarcinoma (PDAC), a particularly aggressive malignancy, has been linked to atypical levels, certain mutations, and aberrant signaling of G-protein-coupled receptors (GPCRs). GPCRs have been challenging to target in cancer because they organize into complex networks in tumor cells. … Excerpt only: this text is the publisher’s. Read it in full at the source.